Fig. 1 · Structure
Documents & Downloads
1,19-Bis(2-butyloctyl) 10-[3-(dimethylamino)propyl(1-oxononyl)amino]nonadecanedioate
Vaccine Excipient
1,19-Bis(2-butyloctyl) 10-[[3-(dimethylamino)propyl](1-oxononyl)amino]nonadecanedioate serves as a vital excipient in vaccine formulations. This compound enhances the stability and delivery efficiency of vaccine components, playing a critical role in the development of COVID-19 vaccines and other immunotherapeutic applications. Its unique structural properties facilitate effective gene delivery, making it valuable in advancing gene therapy research and applications.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2036272-50-9 |
| Applications | Vaccine Excipient |
| Formula | C57H112N2O5 |
| Molecular Weight | 905.51 |
| SMILES | O=C(OCC(CCCC)CCCCCC)CCCCCCCCC(N(CCCN(C)C)C(CCCCCCCC)=O)CCCCCCCCC(OCC(CCCC)CCCCCC)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.